
HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd. (HIVE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HIVE · as of Jun 8, 2026
Key Statistics
Explore HIVE Digital Technologies Ltd. Data
hive stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 77.8%
The HIVE analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $6.42, representing +62.12% upside from the current price of $3.96.
Competitors & Peers
hive competitorsStock Performance
Full HistoryAbout HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd. is a technology company focused on building and operating data centers in Bermuda, exclusively powered by green energy. The firm's operations encompass the mining and su…
what is hive digital technologies ltd. · hive stock overview · hive digital technologies ltd. company profile · who is hive digital technologies ltd. ceo · hive NASDAQ · hive digital technologies ltd. headquarters · hive digital technologies ltd. business segments
About Stock Overview & Key Data
HIVE Digital Technologies Ltd. (HIVE) is a Financial Services company in the Information Technology Services industry, listed on NASDAQ since Feb 2, 2011. As of the latest trading session, HIVE stock price is $3.96, with a market capitalization of $1.1B. The stock has returned +87.56% over the past 12 months and +46.12% year-to-date.
According to 9 Wall Street analysts, the consensus rating for HIVE Digital Technologies Ltd. stock is Buy, with an average 12-month price target of $6.42. In fiscal year 2026, HIVE Digital Technologies Ltd. reported revenue of $297.8M and net income of -$148.4M. For detailed data — including HIVE Digital Technologies Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HIVE Digital Technologies Ltd. (HIVE) stock price is $3.96. The stock is traded on NASDAQ under the ticker symbol HIVE. The 52-week range is $1.60 – $7.84.